Month: May 2022

Backblaze Launches Channel Partner Program

Written by Customer Service on May 12, 2022. Posted in Public Companies.

Combines new Channel Partner team with a package of benefits, rewards, and resources to ease partners’ workload as they engage and grow cloud adoption through the channel SAN MATEO, Calif., May 12, 2022 (GLOBE NEWSWIRE) — Backblaze, Inc. (Nasdaq: BLZE), the leading independent storage cloud platform, today announced the launch of its Channel Partner Program. The launch—which follows the recent announcement of a capacity billing model exclusive to the channel, Backblaze B2 Reserve—includes a suite of benefits, rewards, and resources developed to uplevel ease of use and incentives for resellers and distributors who bring B2 Cloud Storage to their customers. “When it comes to helping businesses get the best of what cloud services have to offer, no one does it better than the channel,” Elton Carneiro, Senior Director, Partnerships...

Autolus Therapeutics to Present Four Clinical Data Updates at the European Hematology Association Congress

Written by Customer Service on May 12, 2022. Posted in Public Companies.

– AUTO4: oral presentation on initial clinical experience in peripheral T cell lymphoma– AUTO1/22: oral presentation on initial experience in r/r pediatric B-cell acute lymphoblastic leukemia– obe-cel: poster presentation in r/r primary CNS lymphoma– obe-cel: poster presentation in r/r B-non-Hodgkins lymphoma and chronic lymphoblastic leukemia– Conference call to be held on June 13, 2022 at 7:30 am EST/12:30 pm BST LONDON, May 12, 2022 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the online publication of four abstracts submitted to the European Hematology Association (EHA) Congress to be held June 9-12, 2022. Autolus plans to present more detail on these programs and the...

Verizon reports preliminary results of shareholder vote at 2022 annual meeting

Written by Customer Service on May 12, 2022. Posted in Public Companies.

IRVING, Texas, May 12, 2022 (GLOBE NEWSWIRE) — Verizon Communications Inc. (NYSE, Nasdaq: VZ) has announced preliminary results of the shareholder vote at its annual meeting, which was held today in Irving, Texas, the company’s first in-person shareholder meeting since 2019. Verizon’s shareholders elected each of Verizon’s eleven directors to a one-year term. Shareholders also voted in favor of two management proposals:Approved the compensation of the company’s named executive officers as described in the 2022 proxy statement; and Ratified the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm.All four shareholder proposals were defeated: report on charitable contributions; amend executive compensation clawback policy; shareholder ratification of annual equity awards; and report...

CORRECTION: Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights

Written by Customer Service on May 12, 2022. Posted in Earnings Releases And Operating Results.

CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline on Thursday, May 12 by Evelo Biosciences, Inc. (Nasdaq: EVLO), please note that in the first sentence of the First Quarter 2022 Financial Results (Unaudited) section, the dates should be “As of March 31, 2022, cash and cash equivalents were $39.6 million, as compared to cash and cash equivalents of $68.4 million as of December 31, 2021,” not December 31, 2021 and March 31, 2021. The corrected release follows: Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today reported financial results and business highlights for the first quarter 2022. “This quarter we reported positive data for EDP1815 in psoriasis in three key areas: effects on systemic inflammatory...

DallasNews Corporation Announces Third Quarter 2022 Dividend

Written by Customer Service on May 12, 2022. Posted in Dividend Reports And Estimates.

DALLAS, May 12, 2022 (GLOBE NEWSWIRE) — DallasNews Corporation (Nasdaq: DALN) announced today that its Board of Directors declared a quarterly cash dividend of $0.16 per share on May 12, 2022. The dividend will be payable on September 2, 2022 to shareholders of record at the close of business on August 12, 2022. About DallasNews Corporation DallasNews Corporation is the Dallas-based holding company of The Dallas Morning News and Medium Giant. The Dallas Morning News is Texas’ leading daily newspaper with a strong journalistic reputation, intense regional focus and close community ties. Medium Giant is a media and marketing agency of divergent thinkers who devise strategies that deepen connections, expand influence, and scale success for clients nationwide. For additional information, visit dallasnewscorporation.com or email invest@dallasnews.com. Statements...

Novartis data at ASCO and EHA showcase latest oncology research and innovation, including in breast and prostate cancer

Written by Customer Service on May 12, 2022. Posted in Public Companies.

Latest in HR+/HER2- metastatic breast cancer, including data on CDK recycling with Kisqali® plus endocrine therapy, further MONALEESA-2 quality of life and overall survival analyses, and a new biomarker analysis of Piqray® plus fulvestrantData for Tafinlar®+ Mekinist®in pediatric patients with BRAF V600 low-grade glioma to be featured in ASCO official press briefingFirst release of 96-week data on Scemblix® in Ph+ CML in chronic phase patients previously treated with ≥2 prior tyrosine kinase inhibitorsUpdated next-generation CAR-T T-Charge™ data, and five-year results from ELIANA trial in pediatric and young adult ALL treated with Kymriah®, the first ever CAR-T cell therapy approvedData from nearly 130 abstracts from Novartis-sponsored and investigator-initiated trials demonstrates Novartis commitment to push the boundaries of...

Progress Releases MOVEit 2022 with Advanced Capabilities to Secure and Simplify File Transfer Across Systems

Written by Customer Service on May 12, 2022. Posted in Public Companies.

New release includes a MOVEit Add-in for Microsoft Outlook that makes securing files with MOVEit simple, intuitive and easy to deploy across the entire organization BURLINGTON, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of infrastructure software, today announced the release of Progress® MOVEit® 2022, the secure, automated Managed File Transfer (MFT) software that can be deployed both on premise and in the cloud. With a new add-in for Microsoft Outlook and advanced security and usability features, MOVEit 2022 makes it easier than ever for organizations to securely and intuitively share sensitive files. “Those who routinely transfer financial, personal and other sensitive data who are concerned about data security, accessibility and compliance—while also maintaining control—need a strong...

Kronos Bio’s Investigational SYK Inhibitors Entospletinib and Lanraplenib to be Featured in Four Poster Presentations at EHA2022 Congress

Written by Customer Service on May 12, 2022. Posted in Public Companies.

Posters include preclinical data on SYK inhibition in combination with targeted agents and demonstrate preclinical anti-tumor activity in acute myeloid leukemia (AML) Additional presentations detail trial designs for Kronos Bio’s Phase 3 registrational study of entospletinib and Phase 1b/2 lanraplenib trial in genetically defined AML SAN MATEO, Calif. and CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer and other serious diseases, today announced that its two novel investigational spleen tyrosine kinase (SYK) inhibitors, entospletinib and lanraplenib, will be featured in poster presentations at the European Hematology Association (EHA) 2022 Congress, being held June 9-12 in Vienna. Kronos Bio is enrolling patients in the...

AB “Rokiškio sūris” dividend payment procedure for the year 2021

Written by Customer Service on May 12, 2022. Posted in Public Companies.

The Annual General Meeting of Shareholders of AB „Rokiškio sūris“ (company code 173057512, address Pramonės str.3, Rokiškis), which took place on 29 April 2022, decided to allocate EUR 0.10 per share for 2021 (the total amount of dividends for 2021 is EUR 3.501 million). Dividends will be paid to those persons who at the end of the tenth business day following the General Meeting of Shareholders accepting the payment of dividends, i.e. May 13, 2022 will be shareholders of AB Rokiškio sūris. As of May 26, 2022, dividends will be paid in the following order:For shareholders whose bookkeeping of AB Rokiškio sūris shares is managed by financial brokerage firms or branches of credit institutions providing securities accounting services, the amount of dividends after deduction of personal income tax or income tax under the laws of the Republic...

MakeMyTrip Limited to Report Fiscal 2022 Fourth Quarter and Full Year Financial & Operating Results on May 25, 2022

Written by Customer Service on May 12, 2022. Posted in Earnings Releases And Operating Results.

Gurugram, May 12, 2022 (GLOBE NEWSWIRE) — MakeMyTrip Limited to Report Fiscal 2022 Fourth Quarter and Full Year Financial & Operating Results on May 25, 2022 Gurugram and New York, May 12, 2022 MakeMyTrip Limited (Nasdaq: MMYT) plans to report its fiscal 2022 fourth quarter and full year financial and operating results before markets open on Wednesday, May 25, 2022. The Company will post the release on its Investor Relations website https://investors.makemytrip.com/ and will not be distributing over newswires. A live Zoom Webinar with the senior management team will also be hosted at 7:30 am EDT or 5:00 pm IST through the company’s Investor Relations website at https://investors.makemytrip.com/. To register for the webinar, please follow this link: https://makemytrip.zoom.us/webinar/register/WN_IrCG4m78THCRM4lkLXMrug Registered...

Month: May 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals